Global Angiographic Entry Needles Market Size By Type (With Wing, Without Wing), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

lobal Angiographic Entry Needles Market Report Description

The Global Angiographic Entry Needles Market was valued at USD 412 million in 2023 and is projected to reach USD 725 million by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The market is primarily driven by the rising prevalence of cardiovascular and peripheral vascular diseases, increasing demand for minimally invasive procedures, and growing awareness about early diagnosis and treatment. Angiographic entry needles are essential for precise vascular access in diagnostic and interventional procedures, supporting safer and more efficient catheter insertion, which is further boosting their global demand.

Drivers:

1. Increasing Burden of Cardiovascular Diseases:

The rising global incidence of cardiovascular conditions, including coronary artery disease and peripheral artery disease, has led to a higher number of angiographic and interventional procedures, directly fueling demand for angiographic entry needles.

2. Technological Advancements in Interventional Radiology:

Innovations such as echogenic tips for enhanced visualization under ultrasound, and integrated safety features to prevent needlestick injuries, are making these devices more efficient and safer, driving their adoption across hospitals and diagnostic centers.

3. Growth in Minimally Invasive Surgeries:

There is a growing preference for minimally invasive techniques due to faster recovery, lower complication risks, and reduced hospital stays, which increases the use of precise vascular access devices like angiographic entry needles.

Restraints:

1. High Cost of Advanced Needles:

Premium-priced needles with integrated safety and imaging features can be expensive, particularly for low-income settings or smaller healthcare facilities, which may hinder market penetration.

2. Risk of Complications and Product Recalls:

While angiographic needles offer precision, incorrect usage or defective devices can lead to complications such as arterial puncture or hematoma. This risk and past product recalls may deter cautious buyers.

Opportunity:

1. Rising Demand in Emerging Economies:

Expanding healthcare infrastructure, especially in Asia-Pacific and Latin America, along with increasing government focus on cardiovascular health, provides significant growth opportunities for manufacturers in these regions.

2. Integration with Imaging Technologies:

The trend toward image-guided interventions presents an opportunity for product innovation, such as developing needles that are more compatible with real-time ultrasound or fluoroscopic imaging.

Market by System Type Insights:

Based on system type, the Single-Wall Entry Needles segment held the largest share in 2023, driven by their widespread use in standard angiographic procedures due to ease of use and cost-efficiency. However, the Double-Wall Needles segment is expected to exhibit the fastest growth during the forecast period, owing to enhanced safety and higher puncture precision in complex procedures.

Market by End-Use Insights:

By end-use, Hospitals and Surgical Centers dominated the global market in 2023, accounting for over 60% of the total revenue. The dominance is attributed to the high volume of diagnostic and therapeutic angiographic procedures performed in hospital settings. Specialty Clinics are expected to grow steadily due to the rising trend of outpatient procedures and increasing availability of vascular specialists in standalone facilities.

Market by Regional Insights:

Geographically, North America led the market in 2023, owing to its advanced healthcare infrastructure, high incidence of vascular disorders, and strong reimbursement frameworks. Meanwhile, Asia-Pacific is expected to register the fastest growth through 2031, driven by increasing healthcare spending, awareness about cardiovascular health, and an expanding medical device market in countries like India and China.

Competitive Scenario:

Key players in the Global Angiographic Entry Needles Market include BD (Becton, Dickinson and Company), Merit Medical Systems, Cook Medical, Terumo Corporation, Argon Medical Devices, Medtronic plc, Teleflex Incorporated, and Boston Scientific Corporation. These companies are focusing on innovation, geographic expansion, and strategic partnerships to maintain competitiveness.

Key Developments:

In 2023, BD launched a new echogenic angiographic entry needle designed to improve visibility in ultrasound-guided procedures.

Terumo expanded its portfolio of vascular access solutions with a series of safety-engineered angiographic needles in 2024.

Merit Medical announced the acquisition of a vascular access startup in 2025, enhancing its needle technology and R&D capabilities.

Scope of Work – Global Angiographic Entry Needles Market

Report Metric Details

Market Size (2023) USD 412 million

Projected Market Size (2031) USD 725 million

CAGR (2023–2031) 7.1%

Market Segments By System Type (Single-W